-
Mashup Score: 0StockWatch: After $50M from Nvidia, Investors Bullish on Recursion - 10 month(s) ago
The appetites of biotech investors for companies expanding in artificial intelligence show no signs of slowing any time soon, as reflected by the stock surge enjoyed by Recursion Pharmaceuticals after Nvidia invested $50 million in the AI-focused drug developer.
Categories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 1Expanding mRNA Manufacturing Techniques - 10 month(s) ago
mRNA therapies are quite simple, but they will inevitably become more complex with products like self-amplifying RNA and big circular molecules.
Categories: Future of Medicine, Latest HeadlinesTweet-
British-based researchers hope to reduce #mRNA production costs by expanding the range of manufacturing techniques. A team has created and is testing a vast library of RNA polymerases that generate mRNA from DNA templates during manufacturing. Learn more: https://t.co/Vm0PM7S9aP https://t.co/uvPWKRdqde
-
-
Mashup Score: 1
Study showed that RANKL inhibitors can restore luminal breast cancer sensitivity to CDK4/6 inhibitors and prevent acquired resistance.
Categories: Future of Medicine, Latest HeadlinesTweet-
Researchers at @IMMolecular and @CNIOStopCancer, have discovered one of the mechanisms leading to luminal breast cancer resistance to targeted CDK4/6 inhibitor therapy and proposed a therapeutic strategy using an existing osteoporosis drug. Learn more: https://t.co/sNGfp72QIz https://t.co/dyiOLuYpyX
-
-
Mashup Score: 6Spatial Transcriptomics Creates Comprehensive Atlas of Macaque Cortex - 10 month(s) ago
A comprehensive cell-type taxonomy has been constructed for the entire macaque cortex using Stereo-seq spatial transcriptomics.
Categories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 5
Study showed that RANKL inhibitors can restore luminal breast cancer sensitivity to CDK4/6 inhibitors and prevent acquired resistance.
Categories: Future of Medicine, Latest HeadlinesTweet-
Researchers at @IMMolecular and @CNIOStopCancer, have discovered one of the mechanisms leading to luminal breast cancer resistance to targeted CDK4/6 inhibitor therapy and proposed a therapeutic strategy using an existing osteoporosis drug. Learn more: https://t.co/sNGfp72QIz https://t.co/JPvAU4IQbE
-
-
Mashup Score: 1Drawing a Bead on Glycans in Biotherapeutics - 10 month(s) ago
Sometimes, more useful applications arise from making more use of existing tools.
Categories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 1Rosalind Franklin Society Awards Recognize Outstanding Contributions from Women and Minorities - 10 month(s) ago
Rosalind Franklin Society Awards in Science announced, recognize outstanding contributions from women and minorities.
Categories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 10
Study showed that RANKL inhibitors can restore luminal breast cancer sensitivity to CDK4/6 inhibitors and prevent acquired resistance.
Categories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 6Spatial Transcriptomics Creates Comprehensive Atlas of Macaque Cortex - 10 month(s) ago
A comprehensive cell-type taxonomy has been constructed for the entire macaque cortex using Stereo-seq spatial transcriptomics.
Categories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 3Drawing a Bead on Glycans in Biotherapeutics - 10 month(s) ago
Sometimes, more useful applications arise from making more use of existing tools.
Categories: Future of Medicine, Latest HeadlinesTweet
StockWatch--The appetites of biotech investors for companies expanding in #artificialintelligence show no signs of slowing any time soon, as reflected by the stock surge enjoyed by Recursion Pharmaceuticals after Nvidia invested $50 million. Learn more: https://t.co/1Mptu7yt47 https://t.co/VlfhQx6M4v